研究業績

2009

Papers (English)

 
Original papers


1. Furukawa Y, Yamaguchi W, Ito K, Hamada T, Miyaji H, Tamamura H, Yamada M. The efficacy of radiation monotherapy for Tolosa-Hunt syndrome. J Neurol (In Press)

2. Hamaguchi A, Takahashi R, Iwasa K, Yamada M. Idiopathic sphenoidal defects detected by 3D-computed tomography. Neurology 73:157-158, 2009

3. Hamaguchi A, Ishida C, Iwasa K, Abe A, Yamada M. Charcot-Marie-Tooth disease type 2D with a novel Glycyl-tRNA synthetase gene (GARS) mutation. J Neurol (In Press)

4. Hamaguchi T, Morinaga A, Tsukie T, Kuwano R, Yamada M. A novel presenilin 1 mutation (L282F) in familial Alzheimer’s disease. J Neurol 256:1575-1577, 2009

5. Hamaguchi T, Noguchi-Shinohara M, Nozaki I, Nakamura Y, Sato T, Kitamoto T, Mizusawa H, Yamada M. The risk of iatrogenic Creutzfeldt-Jakob disease through medical and surgical procedures. Neuropathology 29:625-631, 2009

6. Hamaguchi T, Noguchi-Shinohara M, Nozaki I, Nakamura Y, Sato T, Kitamoto T, Mizusawa H, Yamada M. Medical procedures and risk for sporadic Creutzfeldt-Jakob disease, Japan, 1999-2008. Emerg Inf Dis 15:265-271, 2009

7. Hamaguchi T, Ono K, Murase A, Yamada M. Phenolic compounds prevent Alzheimer’s pathology through different effects on the amyloid β-aggregation pathway. Am J Pathol 175:2557-2565, 2009

8. Hamaguchi T, Yamada M. Basiparallel anatomic scanning-magnetic resonance imaging in vertebral artery dissection. Arch Neurol 66:276-277, 2009

9. Hirohata M, Ono K, Morinaga A, Ikeda T, Yamada M. Anti-aggregation and fibril-destabilizing effects of sex hormones on α-synuclein fibrils in vitro. Exp Neurol 217:434-439, 2009

10. Hirohata M, Yoshita M, Ishida C, Ikeda S, Tamaoka A, Kuzuhara S, Shoji M, Ando Y,
Tokuda T, Yamada M. Clinical features of non-hypertensive lobar intracerebral hemorrhage related to cerebral amyloid angiopathy. Eur J Neurol (In Press)

11. Ho L, Chen LH, Wang J, Zhao W, Talcott ST, Ono K, Teplow DB, Humala N, Cheng A,
Percival SS, Ferruzzi M, Janle E, Weaver C, Dickstein DL, Pasinetti GM. Heterogeneity in red wine polyphenolic contents differentially influences Alzheimer’s disease-type neuropathology and cognitive deterioration. J Alzheimers Dis 16:59-72, 2009

12. Ikeda T, Noto D, Noguchi-Shinohara M, Ono K, Takahashi K, Ishida C, Yoshita M,
Kawaguchi M, Kawahara N, Iwasa K, Tomita K, Yamada M. CSF tau protein ins a useful marker for effective treatment of superficial siderosis of the central nervous system: Two case reports. Clin Neurol Neurosurg (In Press)

13. Ikeda T, Takahashi K, Kabata T, Sakagoshi D, Tomita K, Yamada M. Polyneuropathy caused by cobalt-chromium metallosis after total hip replacement. Muscle & Nerve (In Press)

14. Ikeda T, Ono K, Elashoff D, Condron MM, Noguchi-Shinohara M, Yoshita M, Teplow DB, Yamada M. Cerebrospinal fluid of Alzheimer patients promotes amyloid β-protein oligomerization. J Alzheimers Dis (In Press)

15. Ikeda Y, Abe K, Ishida C, Takahashi K, Hayasaka K, Yamada M. A clinical phenotype of distal hereditary motor neuronopathy type II with a novel HSPB1 mutation. J Neurol Sci 277:9-12, 2009

16. Ishida C, Makifuchi T, Saiki S, Hirose G, Yamada M. A neuropathological study of autosomal-dominant chorea-acanthocytosis with a mutation of VPS13A. Acta Neuropathol 117:85-94, 2009

17. Ishida C, Saiki S, Yamada M. Reply: Chorea-acanthocytosis with an autosomal-dominant trait. Acta Neuropathol 117:97-98, 2009

18. Kato-Motozaki Y, Komai K, Takahashi K, Ishida C, Ueda M, Kusunoki S, Yamada M. Polyethylene glycol interferon α-2b-induced immune-mediated polyradiculoneuropathy. Intern Med 48:569-572, 2009

19. Kojima Y, Sakai K, Ishida C, Asaka T, Hamaguchi T, Nozaki I, Fukushima K, Tsuchiya A, Kametani F, Yazaki M, Okino S, Yamada M. Hereditary rimmed vacuole myopathy showing interstitial amyloid deposition in muscle tissue. Muscle Nerve 40:472-475, 2009

20. Maruta T, Yoshikawa H, Fukasawa S, Umeshita S, Inaoka Y, Edahiro S, Kado H, Motozaki Y, Iwasa K, Yamada M. Autoantibody to dihydropyridine receptor in myasthenia gravis. J Neuroimmunol 208:125-129, 2009

21. Morinaga A*, Hasegawa K*, Nomura R, Ookoshi T, Ozawa D, Goto Y, Yamada M, Naiki H. Critical role of interfaces and agitation on the nucleation of Aβ amyloid fibrils at low concentrations of Aβ monomers. Biochem Biophys Acta - Proteins and Proteomics (In Press) *equally contributed

22. Noguchi-Shinohara M, Tokuda T, Yoshita M, Kasai T, Ono K, Nakagawa M, Omar M.A. El-Agnaf, Yamada M. CSF α-synuclein levels in dementia with Lewy bodies and Alzheimer’s disease. Brain Res 1251:1-6, 2009

23. Noto D, Takahashi K, Hamaguchi T, Inamura K, Nobata K, Yazaki M, Ikeda S, Kobayashi K, Yamada M. A case of adult onset type II citrullinemia with portal-systemic shunt. J Neurol Sci 281:127-129, 2009

24. Noto D, Takahashi K, Miyake S, Yamada M. In vitro differentiation of lineage-negative bone marrow cells into microglia-like cells. Eur J Neurosci (In Press)

25. Nozaki I*, Arai M*, Takahashi K, Hamaguchi T, Yoshikawa H, Muroishi T,
Nouguchi-Shinohara M, Ito H, Itokawa M, Akiyama H, Kawata A, Yamada M. Familial ALS with G298S mutation in TARDBP: A comparison of CSF tau protein levels with those in sporadic ALS. Intern Med (In Press) *equally contributed

26. Ono K, Condron MM, Teplow DB. Structure-neurotoxicity relationships of amyloid β-protein oligomers. Proc Natl Acad Sci U S A 106:14745-14750, 2009

27. Sakai K, Hamaguchi T, Yamada M. Multiple cranial nerve enhancement on MRI in primary Sjögren’s syndrome. Intern Med (In Press)

28. Shibata-Hamaguchi A, Ishida C, Iwasa K, Yamada M. Prevalence of spinocerebellar degenerations in the Hokuriku district, Japan. Neuroepidemiology 32:176-183, 2009

29. Shinde A, Kunieda T, Kinoshita Y, Wate R, Nakano S, Ito H, Yamada M, Kitamoto T,
Nakamura Y, Matsumoto S, Kusaka H. The first Japanese patient with variant Creutzfeldt-Jakob disease (vCJD). Neuropathology 29:713-719, 2009

30. Suzuki S, Utsugisawa K, Yoshikawa H, Motomura M, Matsubara S, Yokoyama K, Nagane Y, Maruta T, Satoh T, Sato H, Kuwana M, Suzuki N. Autoimmune targets of heart and skeletal muscles in myasthenia gravis. Arch Neurol (In Press)

31. Takahashi K, Komai K, Ishida C, Tagami A, Machiya T, Shima K. Progressive myelopathy with hyperintensity on T2-weighted spinal MRI. (Question) J Clin Neurosci (In Press)

32. Takahashi K, Komai K, Ishida C, Tagami A, Machiya T, Shima K. Progressive myelopathy with hyperintensity on T2-weighted spinal MRI. (Answer) J Clin Neurosci (In Press)

33. Yamada M, Noguchi-Shinohara M, Hamaguchi T, Nozaki I, Kitamoto T, Sato T, Nakamura Y, Mizusawa H. Dura mater graft-associated Creutzfeldt-Jakob disease in Japan: Clinicopathological and molecular characterization of the two distinct subtypes. Neuropathology 29:609-618, 2009

34. Wright CB, Moon Y, Pakic MC, Brown TR, Rabbani L, Yoshita M, DeCarli C, Sacco R, Elkind MS. Inflammatory biomarkers of vascular risk as correlates of leukoariosis. Stroke 40:3466-3471, 2009

35. Zhao W, Wang J, Ho L, Ono K, Teplow DB, Pasinetti GM. Identification of antihypertensive drugs which inhibit amyloid β-protein oligomerization. J Alzheimers Dis 16:49-57, 2009
 
Reviews


1. Morinaga A, Ono K, Yamada M. New therapeutic strategy for amyloidosis. Future Neurol 4:287-289, 2009

2. Hamaguchi T, Ono K, Yamada M. Curcumin and Alzeheimer’s disease. CNS Neurosci Ther (In Press)
 
Book


1. Mayda A, Yoshita M, DeCarli C. White matter hyperintensities in aging and dementia. In Jagust W and D’Eposito M, ed. Imaging the Aging Brain. Oxford University Press, New York, pp273-291, 2009
 
 

Presentations (International meeting)

 
Invited lectures


1. Takamori M. Synaptic Structure and Function Affected by Various Antibodies in Neuromuscular Transmission. The 4th International Medical Biotech Forum. Dalain, August 8-10, 2009

2. Yamada M, Nakamura Y. CJD Surveillance in Japan. European CJD Survellance Network. Stockholm, June 4-5, 2009
 
Presentations


1. Carmichael O, Drucker D, Schwarz C, Fletcher E, Martinez O, Yoshita M, He J, DeCarli C. Longitudinal changes in cognition and cerebrovascular disease in the Alzheimer's Disease Neuroimaging Initiative. The 61st Annual Meeting of American Academy of Neurology, Seattle, April 25-May 5, 2009

2. Chalmers K, Love S, Ince P, Esiri M, Attems J, Jellinger K, Yamada M, McCarron M, Joachim C, Frosch M, Mann D, Nicoll J, Thal D, Kehoe P. Validation of international consensus criteria for the assessment of cerebral amyloid angiopathy in post-mortem brain. Sixth International Congress on Vascular Dementia, Barcelona, November 19-22, 2009

3. Dong C, Yoshita M, DeCarli C, Gervasi-Franklin P, Rundek T, Sacco RL, Wright CB. Sex difference in the relationship between waist-hip ratio and silent brain infarction in a multiethnic cohort from the Northern Manhattan Study (NOMAS). World Hypertension Congress, Beijing, October 29-November 1, 2009

4. Matsunari I, Shima K, Samuraki M, Chen W, Yanase D, Takeda N, Yoshita M, Kinuya S, Yamada M. Age-related brain structural changes exceed metabolic alteration in the young to middle-age adults: The Ishikawa Brain Imaging Study. 2009Annual meeting of the society of nuclear medicine, Toronto, June 13-17, 2009

5. Marcus JR, Gardener H, Yoshita M, Guzman J, Elkind MSV, Sacco RL, DeCarli C, Wright CB. Diastolic and not systolic blood pressure is associated with subclinical cerebrovascular damage: The Northern Manhattan Study. The 61st Annual Meeting of American Academy of Neurology, Seattle, April 25-May 5, 2009

6. Ono K, Teplow DB, Condron MM. The English (H6R) and Tottori (D7N) familiar Alzheimer disease mutations accelerate amyloid β-protein oligomerization and cytotoxicity. Neuroscience Nanosymposium 2009, Chicago, October 17-21, 2009

7. Pasinetti GM, Ksiezak-reding H, Yemul S, Ono K, Lobo J, Janle E, Ferruzzi M, Wang J, Teplow DB, Ho L. Grape seed polyphenolic extracts (GSPE) as a potential novel treatment in progressive supranuclear palsy: Experimental approaches and therapeutic implications. Neuroscience Nanosymposium 2009, Chicago, October 17-21, 2009

8. Romero JR, Beiser A, Seshadri S, Kase CS, Kelly-Hayes M, Au R, He J, Yoshita M, DeCarli C , Wolf PA. Silent cerebral infarction incidence exceeds that of clinical stroke in mid-life: The Framingham Heart Study. International Stroke Conference 2009, San Diego, February 17-20, 2009

9. Sanjo N, Shiga Y, Sato T, Yuasa T, Nakamura K, Kitamoto T, Yamada M, Mizusawa H. MRI evidence of early cerebellar involvement in dura mater graft-associated Creutzfeldt-Jacob disease. Prion 2009, Chalkidiki, September 23-25, 2009

10. ShigaY, Nakamura Y, Hisanaga K, Yamada M, Mizusawa H. Potential risk factors for sporadic Creutzfelt-Jacob disease. The 61st Annual Meeting of American Academy of Neurology, Seattle, April 25-May 5, 2009

11. Takahashi K, Noto D, Yamada M. In vitro differentiation of lineage negative bone marrow cells into microglia. 9th European Meeting on Glial Cells in Health and Disease, Paris, September 8-12, 2009

12. Teplow DB, Ono K, Condron MM. Structure-neurotoxicity relationships of amyloid β-protein oligomers. Neuroscience Nanosymposium 2009, Chicago, October 17-21, 2009

13. Yoshita M, Noto D, Takahashi K, Yamada M. Comparative value of brain MRI and 123I-MIBG myocardial scintigraphy in distinguishing amongst Lewy body disease, progressive supranuclear palsy and corticobasal degeneration. The 61st Annual Meeting of American Academy of Neurology, Seattle, April 25-May 5, 2009
 
TOPへ戻る